Autres langues Lipidor AB

Actions

LIPI

SE0012558617

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:39 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,235 ^SEK	+2,17 %		-0,42 %	-53,37 %

21/03	Lipidor AB (publ) annonce l'approbation du démarrage de l'essai clinique de phase III du candidat médicament AKP02G2 pour le traitement du psoriasis	CI
28/02	Lipidor AB (publ) annonce ses résultats pour le quatrième trimestre et l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lipidor AB announces new date for publication of Annual Report 2023	22/04
NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)	10/04
Lipidor resolves on a rights issue of approximately SEK 58.0 million and enters into a co-investment agreement which secures funding for the implementation of the upcoming phase III study	10/04
Lipidor completes planned divestment of shares in Emollivet	26/03
Lipidor announces approval for start of Phase III clinical trial of psoriasis candidate AKP02G2	21/03
Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2	21/03
Lipidor adds capital through sale of shares	06/03
Lipidor AB (publ) publishes year-end report for 2023	28/02
Lipidor AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Lipidor completes SEK 1.7 million sale of animal segment patent	24/01
Lipidor adds 1.1 MSEK through sale of shares in associated company and agreement of loan	21/12
Lipidor Seeks Approval for Late-stage Study of Plaque Psoriasis Medicine in India	20/12
Lipidor applies to the Indian Medical Products Agency to start a Phase III study of AKP02G2	20/12
Lipidor Applies to the Indian Medical Products Agency to Start A Phase III study of AKP02G2	20/12
Lipidor presents Nomination Committee	05/12
Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Lipidor AB (publ) publishes interim report for Q3 2023	22/11
Lipidor AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Lipidor Files New Patent Application for Akvano Technology in EU	27/10/23
Lipidor submits new patent application	27/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Lipidor AB

Actions

LIPI

SE0012558617

Autres langues

Filtres